复方樟脑乳膏治疗局限性神经性皮炎的疗效和安全性分析  被引量:1

Efficacy and safety of compound camphor cream in the treatment of localized neurodermatitis

在线阅读下载全文

作  者:马自然 MA Ziran(Liaoning Jianping County Hospital,Chaoyang 122400,China)

机构地区:[1]辽宁省建平县医院,122400

出  处:《中国现代药物应用》2021年第18期153-155,共3页Chinese Journal of Modern Drug Application

摘  要:目的探讨复方樟脑乳膏治疗局限性神经性皮炎的疗效和安全性。方法100例局限性神经性皮炎患者作为研究对象,通过双盲选法分为参照组和研究组,每组50例。参照组患者选择丹皮酚软膏进行治疗,研究组患者选择复方樟脑乳膏进行治疗。比较两组临床疗效及不良反应发生情况。结果治疗2周后,研究组患者的治疗总有效率84.00%显著高于参照组的66.00%,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义(χ^(2)=0.709,P=0.400>0.05)。结论在局限性神经性皮炎患者的临床治疗中,复方樟脑乳膏治疗价值显著,不仅可以提高患者的治疗效果,同时还不易发生不良反应,无论是治疗效果还是治疗安全性均较为理想,建议推广。Objective To discuss the efficacy and safety of compound camphor cream in the treatment of localized neurodermatitis.Methods A total of 100 patients with localized neurodermatitis as study subjects were divided into reference group and research group according to double-blind method,with 50 cases in each group.The reference group was treated with Paeonol ointment,and the research group was treated with compound camphor cream.The clinical efficacy and occurrence of adverse reactions were compared between the two groups.Results After 2 weeks of treatment,the total effective rate 84.00%of the research group was significantly higher than 66.00%of the reference group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in incidence of adverse reactions between the two groups(χ^(2)=0.709,P=0.400>0.05).Conclusion Compound camphor cream has significant therapeutic value in patients with localized neurodermatitis,which can not only improve the therapeutic effect,but also is not prone to adverse reactions.Both the therapeutic effect and the safety of the treatment are relatively ideal,and it is recommended to be promoted.

关 键 词:局限性神经性皮炎 复方樟脑乳膏 治疗效果 不良反应 

分 类 号:R758.2[医药卫生—皮肤病学与性病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象